The current study was prepared to provide data supporting the response to the proposed changes from several allergy and immunology specialty organizations.
Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.
Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research presented today at EuroHeartCare 2016.
Scientific and regulatory troubles continue to mount for Theranos, the much-touted blood-testing startup.
New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.
The indication of decreased risk was seen across all types of coffee, both caffeinated and decaffeinated.
Vitamin D supplements during pregnancy and infancy may help to reduce New Zealand’s high childhood allergy rate.
It is very hard to predict which cells become aggressive or not.
Blood flow, blood pressure and heart rate were monitored during the exercise.
The team's ultimate goal will be to use the data acquired to design the next generation of compounds that will be validated and tested for reduced toxicity and decreased resistance.
The results of C-EDGE Head-to-Head will be featured in the official press program at The International Liver Congress 2016.
Researchers have shown that various types of intestinal bacteria might be factors in both causing and preventing obesity.
The small pipeline of schizophrenia products — about 135 products — is indicative of a low level of investment in research and development (R&D). Here's why.
Scientists discovered this over-the-counter drug could have special properties.
Confirming the worst fears of many pregnant women in the United States and Latin America, U.S. health officials said Wednesday there is no longer any doubt the Zika virus causes babies to be born with abnormally small heads and other severe brain defects.